Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of IV Lidocaine and Epidural Ropivacaine in Abdominal Surgery
NCT05368753Phase 4Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Mar 2022
- Primary completion
- Jan 2024
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Lidocaine Hydrochloride Injection, without epinephrine and ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by CHU Amiens-Picardie. Primary endpoints: Blood lidocaine concentration, Blood lidocaine and ropivacaine concentration at 2 hours and 1 more. Started Mar 2022; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05368753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05368753.